ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited - PE Ratioverified

ASLN

Price:

$0.6

Market Cap:

$777.12M

ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the...[Read more]

Industry

Biotechnology

IPO Date

2018-05-04

Stock Exchange

NASDAQ

Ticker

ASLN

The PE Ratio as of June 2026 (TTM) for ASLAN Pharmaceuticals Limited (ASLN) is -0.04

According to ASLAN Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -99.22% compared to the average of -4.79 of the last 4 quarters.

ASLAN Pharmaceuticals Limited (ASLN) Historical PE Ratio (quarterly & annually)

How has ASLN PE Ratio performed in the past?

The mean historical PE Ratio of ASLAN Pharmaceuticals Limited over the last ten years is -7.19. The current -0.04 PE Ratio has changed -47.81% with respect to the historical average. Over the past ten years (40 quarters), ASLN's PE Ratio was at its highest in in the September 2016 quarter at 60.98. The PE Ratio was at its lowest in in the June 2021 quarter at -21.15.

Quarterly (TTM)
Annual

Average

-7.19

Median

-4.66

Minimum

-32.43

Maximum

-0.39

ASLAN Pharmaceuticals Limited (ASLN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ASLAN Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 376.20%

Maximum Annual PE Ratio = -0.39

Minimum Annual Increase = -78.85%

Minimum Annual PE Ratio = -32.43

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.39-60.29%
2022-0.98-76.77%
2021-4.21-46.39%
2020-7.85180.50%
2019-2.80-45.24%
2018-5.11-25.44%
2017-6.86-78.85%
2016-32.43249.71%
2015-9.27376.20%

ASLAN Pharmaceuticals Limited (ASLN) Average PE Ratio

How has ASLN PE Ratio performed in the past?

The current PE Ratio of ASLAN Pharmaceuticals Limited (ASLN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.86

5-year avg

-3.25

10-year avg

-7.19

ASLAN Pharmaceuticals Limited (ASLN) PE Ratio vs. Peers

How is ASLN’s PE Ratio compared to its peers?

ASLAN Pharmaceuticals Limited’s PE Ratio is less than Intercept Pharmaceuticals, Inc. (5.58), greater than Icosavax, Inc. (-6.88), greater than Chimerix, Inc. (-8.67), greater than Avid Bioservices, Inc. (-5.61), greater than Ikena Oncology, Inc. (-1.29), greater than Harpoon Therapeutics, Inc. (-1.14), greater than Albireo Pharma, Inc. (-5.61), greater than Poseida Therapeutics, Inc. (-6.94), greater than Exscientia plc (-3.11), less than Niagen Bioscience Inc (14.94),

Build a custom stock screener for ASLAN Pharmaceuticals Limited (ASLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ASLAN Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ASLAN Pharmaceuticals Limited (ASLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ASLAN Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is ASLAN Pharmaceuticals Limited's PE Ratio?

How is the PE Ratio calculated for ASLAN Pharmaceuticals Limited (ASLN)?

What is the highest PE Ratio for ASLAN Pharmaceuticals Limited (ASLN)?

What is the 3-year average PE Ratio for ASLAN Pharmaceuticals Limited (ASLN)?

What is the 5-year average PE Ratio for ASLAN Pharmaceuticals Limited (ASLN)?

How does the current PE Ratio for ASLAN Pharmaceuticals Limited (ASLN) compare to its historical average?